Luca Testa, C3 2019 – New Generation Bioabsorbable Polymer DES Versus Permanent Polymer DES?
We spoke to Dr Luca Testa (Department of Cardiology, IRCCS Policlinico San Donato, Milan, Italy) at C3 2019 about new bioabsorbable versus existing permanent polymer drug-eluting stents, their potential limitations and what he expects to see in the future for these new stents, and their impact on future practice.
Speaker’s Disclosures: Luca Testa has nothing to declare in relation to this video interview.
Questions:
1. Does bioabsorbable polymer drug-eluting stent (DES) technology offer a clinical improvement over a polymer DES? (0:04)
2. Long-term data for these non-polymer approaches are still scarce – what do you expect to see in the coming years, and what impact on practice might non-polymer DES approaches have? (1:53)
touchCARDIO.com is an independent information resource supporting physicians, clinicians and leading industry professionals in continuously developing their knowledge, effectiveness and productivity, via free-to-access content in multimedia formats.
Filmed in partnership with C3 at the 2019 annual meeting in Orlando, Florida, June 2019.